Genes may determine success of hip replacement surgeryMarch 15, 2007The success of long term hip replacement surgery may lie in the genes, suggests research published ahead of print in the Annals of the Rheumatic Diseases. The researchers analysed genetic variations in 312 people, just over half of whom (162) had problems after hip replacement in the 10 years following surgery. Among those with symptoms, 91 had early signs of "aseptic loosening," which describes a condition in which the artificial joint comes loose and the surrounding bone begins to dissolve. The other 71 patients had deep-seated infection, which occurs when the body is unable to control infection caused by bacteria colonising the artificial implants. DNA samples were taken from all participants to test for genetic variations in genes responsible for generating matrix metalloproteinase 1, or MMP1 for short, interleukin 6, and vitamin D synthesis. MMP1 is an enzyme that breaks down collagen, the main protein found in bone and cartilage, while interleukin 6 is a chemical involved in bone metabolism and the immune response. Vitamin D synthesis is important for strong healthy bones. Variations in the interleukin 6 gene did not seem to have any effect. But those with variations in MMP1 were more than three times as likely to have aseptic loosening as those who did not carry the genetic variation. And variations in the vitamin D receptor gene almost doubled the chances of bone dissolution and deep infection. The authors conclude that if confirmed in other research, these findings could be used to predict long term success in patients undergoing hip replacement surgery. And they could also be used to develop targeted genetic treatments. BMJ-British Medical Journal |
|||||||||||||||||||||
| Related Hip Replacement Surgery Current Events and Hip Replacement Surgery News Articles Trimming US health care spending will require new approaches, study finds Slowing the growth in U.S. health care spending will most likely require adoption of an array of strategies as well as an improved approach to moving promising strategies into widespread use, according to a new analysis by the RAND Corporation. Study outlines strategies to test new payment models for health care A new RAND Corporation study outlines methods that might be used to test a novel payment system for medical care that would provide doctors, hospitals and other health providers a set fee for treating an ailment such as hip replacement surgery. How often do hip and knee replacements need revision? A comprehensive study using nationwide data on hip and knee replacements in England has found that one in seventy-five patients require a revision of their joint replacement after three years. NIST measuring device aims to up hip operation success Researchers at the National Institute of Standards and Technology (NIST) are developing state-of-the-art measuring techniques, similar to those used in making aerospace components fit together precisely, that soon could improve success rates for hip replacement surgery. New biomedical device uses nanotechnology to monitor hip implant healing, may reduce wait times It is so small, you can barely see it, but a microsensor created by University of Alberta engineers may soon make a huge difference in the lives of people recovering from hip replacement surgery. Anti-inflammatory drugs following hip replacement surgery could harm rather than help The use of anti-inflammatory drugs following hip replacement surgery could do more harm than good. Bayer launches Phase III clinical study of Trasylol in elective spinal fusion surgery Bayer Pharmaceuticals Corporation (NYSE: BAY) today announced the initiation of a Phase III clinical trial to evaluate the safety and efficacy of Trasylol® (aprotinin injection) in reducing blood loss and the need for transfusion in adult patients undergoing elective spinal fusion surgery. Smith & Nephew launches Oxinium - a significant technological advance to finding a hip replacement that will last a lifetime 1 April 2004, London, UK - A breakthrough in hip replacement technology from orthopaedic specialists, Smith & Nephew, means that nine million people who suffer with arthritis or chronic hip injury in the UK can now benefit from the new Oxinium hip, which could last their lifetime due to its superior strength and endurance. It also means that younger patients who have suffered severe pain and immobility while waiting years to be offered a hip replacement, may no longer have to. In the UK, of the nine million people who suffer with arthritis, 50,000 need hip replacements each year due to osteoarthritis, but orthopaedic surgeons have traditionally delayed joint replacement surgery in patients y Need for hip replacements could double within next 30 years Researchers estimated the likely numbers of hip replacements needed in the UK according to projected changes in population, numbers in each age band, and data from Sweden, which has a similar universal health care system and equivalent rates of osteoarthritis, but where attempts have been made to prioritise demand. More Hip Replacement Surgery Current Events and Hip Replacement Surgery News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||